Novo Nordisk A/S
Stocks making the biggest moves midday: Macy’s, MicroStrategy, Coinbase, Nvidia and more
Check out the companies making headlines in midday trading: Nvidia — Shares of the artificial intelligence darling fell 1% after a rare negative call on Wall Street . New Street Research downgraded Nvidia to hold from buy, citing limited upside given the big run already this year. It is only the second downgrade of Nvidia […]
Read More
Stocks building the most important moves premarket: Macy’s, Tesla, Novo Nordisk and much more
Check out the businesses generating headlines ahead of the bell. Crypto stocks — Shares tied to bitcoin rate slid following the cryptocurrency dropped 5% to its lowest amount considering that February , with the now defunct Mt. Gox exchange commencing repayments to creditors, as expected . Coinbase and MicroStrategy each individual lost 5% in premarket […]
Read More
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. George Frey | Reuters Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition. Semaglutide, which is present in weight loss drugs including Novo Nordisk’s Ozempic […]
Read More
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Aamir Ahmed Khan, PhD, Principal Electrical Engineer for Paradromics, works on the Transceiver which connects to the brain implants. Austin based Paradromics is developing a brain-computer interface to aide disabled and non-verbal patients with communication. Julia Robinson […]
Read More
Shares generating the major midday moves: Tesla, Polestar, Paramount Global and much more
Test out the providers earning headlines in midday investing: Tesla — Tesla surged approximately 9% after the electrical automobile company claimed stronger-than-anticipated second-quarter deliveries. The Elon Musk-led organization sent 443,956 cars, though analysts polled by StreetAccount envisioned deliveries of 439,000. The determine confirmed a 4.8% decline from a year ago but was 14.8% previously mentioned […]
Read More
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Eli Lilly, Novo Nordisk and other drugmakers showed off encouraging data […]
Read More
Shares producing the largest moves midday: SolarEdge Systems, Pool Corp., Carnival and more
Verify out the corporations making headlines in midday trading: SolarEdge Systems — Shares of the company tumbled 20.6% next the announcement that it will offer $300 million worthy of of convertible notes due 2029. The business also unveiled in a U.S. Securities and Trade Commission filing on Monday that a shopper will not likely be […]
Read More
Novo Nordisk’s Wegovy weight loss drug approved in China
Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto | Getty Images Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management, opening up the blockbuster drug for sale in the world’s second largest economy. China’s National Medical Products Administration “recently” […]
Read More
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Novo Nordisk’s new manufacturing facility in Clayton, North Carolina. Courtesy: Novo Nordisk Novo Nordisk on Monday said it will spend $4.1 billion to build a new manufacturing plant in Clayton, North Carolina, in a bid to boost the supply of its blockbuster weight loss drug Wegovy, diabetes treatment Ozempic and other injectable therapies. Demand for […]
Read More
Excess weight loss drug contender Zealand Pharma jumps 23% on demo success
Vials on the Wegovy line at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Friday, March 8, 2024. Bloomberg | Bloomberg | Getty Photos LONDON — Shares of Denmark’s Zealand Pharma popped approximately 23% in Friday early morning deals, notching a record higher soon after an early-phase analyze of its fat decline drug […]
Read More